Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Anxiety Disorders 2Weight Loss 1Recurrence 1Lung Neoplasms 1Glioma 1Fatigue 1Depression 1Colorectal Adenocarcinoma 1Carcinoma, Non-Small-Cell Lung 1Cachexia 1Brain Neoplasms 1Advanced Cancer 1Adenocarcinoma of Lung 1

Interventions

Exercise 35Therapeutics 30Modafinil 21Yoga 17Surveys and Questionnaires 16Methylphenidate 16Psychiatric Rehabilitation 14Acupuncture Therapy 11Educational Status 9Walking 8Early Intervention, Educational 8Cognitive Behavioral Therapy 8Ultraviolet Therapy 7Control Groups 7Therapeutic Touch 6Physical Therapy Modalities 6Mental Status and Dementia Tests 6Exercise Therapy 6Acceptance and Commitment Therapy 6Sugars 5Qigong 5Palliative Care 5Counseling 5Standard of Care 4Saline Solution 4Methods 4Epoetin Alfa 4Dexamethasone 4Behavior Therapy 4Acupressure 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Fatigue × Fluoxetine × Clear all
NCT00005850 2016-07-04

Combination Chemotherapy Plus Fluoxetine in Treating Patients With Advanced or Recurrent Non-Small Cell Lung Cancer

Alliance for Clinical Trials in Oncology

Phase 2 Completed
21 enrolled
Thoracic

Adenocarcinoma of Lung, Anxiety Disorders, Carcinoma, Non-Small-Cell Lung, Depression, Fatigue, Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡